Objectives:

1. Describe the use of IV ketamine as an adjuvant analgesia to opioids for cancer pain

2. Discuss the clinical trial data for use of IV ketamine in cancer pain
3. Discuss the toxicities associated with IV ketamine

Session date: 
01/04/2018 - 8:00am to 9:00am CST
Location: 
UCMC
Chicago, IL 60637
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Michael Huber, MD